The report will be delivered in 2-3 business days.

Gastric Cancer Drugs Global Market Report 2019

Starting Price : $ 4000.00 | Pages : 200 | Published : December 2019 | SKU CODE : 7231 | Format :


The gastric cancer drugs market consists of sales of drugs for gastric cancer. Gastric cancer, also known as stomach cancer, is the formation of abnormal cells on the lining of stomach resulting in stomach pain and indigestion.

The global gastric cancer drugs market was valued at about $1.4 billion in 2018 and is expected to grow to $2.13 billion at a CAGR of 11.1% through 2022.

Asia Pacific was the largest region in the gastric cancer drugs market in 2018 and is forecasted to register the highest CAGR during 2018-2023.

Increasing number of obesity cases and smoking population increased number of people suffering from gastric cancer. Consuming tobacco and following diet unhealthy diet increases the risk of stomach cancer. According to American Institute For Cancer Research ,1 million new cases of stomach cancer have been reported in 2018. Similarly, according to the estimates of American Cancer Society in 2019, about 27,510 cases of stomach cancer will be diagnosed and 11,140 people will die from stomach cancer. Increase in number of cases in gastric cancer will drive the market for gastric cancer drugs.

Stringent regulations and policies for approval of the drugs restrain the market for gastric cancer drugs. Different regions have their own set of rules, guidelines and regulations set by their respective drugs regulation board. For example, the USFDA regulations for American pharmaceuticals states various conditions with regards to safety and effectiveness of the drug as well as certain labeling requirements. Similarly, the European medicines agency (EMA) gives licenses to the approved drugs before they can be marketed or commercialized in the European continent. Teysuno, a drug for advanced gastric cancer can be only obtained through a valid prescription and the protocol is that every company must assess the effects of using Teysuno and must list out the precautions to be taken by patients and healthcare providers to minimize any possible side effects. These regulations hinder the growth of the gastric cancer drugs market.

Many companies are using combination therapies to cure gastric cancer. Combination therapies help in treating patients with two or more drugs for a single disease and help in better treating the patients. For instance, in 2019, the USFDA has approved Taiho Oncology Inc’s combined product LONSURF trifluridine/tipiracil for pretreated metastatic gastric cancer. This approval is significant for patients living with advanced gastric or GEJ (gastroesophageal junction) adenocarcinoma who have limited effective treatment options after failure of standard treatment options. Advances in the drugs for treatment of gastric cancer will have a positive influence on the gastric cancer drugs’ market.

The gastric cancer drugs market is regulated by government agencies such as European Medicines Agency (EMA), USFDA (the US food and drug ministration), and others. For instance, FDA's Current Good Manufacturing Practice (CGMP) regulation lays down minimum requirements for the methods and facilities used in manufacturing, processing, and packing of a drug product and ensures the quality of drugs produced by manufacturers. Moreover, FDA's guidance provides recommendations to applicants for cancer clinical trials and shows support in new drug applications (NDAs), biologics license applications (BLAs), or supplemental applications.

On April 2019, AstraZeneca, a multinational pharmaceutical and biopharmaceutical company acquired Daiichi Sankyo for $1.35 billion. This acquisition will help AstraZeneca to jointly develop drug Trastuzumab Deruxtecan with Daiichi Sankyo. This drug would help to treat people suffering from breast and gastric cancer. Daiichi Sankyo headquarted at Japan is a global pharmaceutical company which offers innovative products and a robust pipeline for cancer treatment.

Major players in the market are Eli Lilly and company, Novartis, Merck KGaA, Otsuka Pharmaceutical, F. Hoffmann-La Roche

    1. Executive Summary

    2. Gastric Cancer Drugs Market Characteristics

    3. Gastric Cancer Drugs Market Size And Growth

    3.1. Global Gastric Cancer Drugs Historic Market, 2014 - 2018, $ Billion

    3.1.1. Drivers Of The Market

    3.1.2. Restraints On The Market

    3.2. Global Gastric Cancer Drugs Forecast Market, 2018 - 2022F, 2025F, 2030F, $ Billion

    3.2.1. Drivers Of The Market

    3.2.2. Restraints On the Market

    4. Gastric Cancer Drugs Market Segmentation

    4.1. Global Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Doxorubicin Hydrochloride

    Sunitinib

    Docetaxel

    Mitomycin

    Fluorouracil

    Imatinib

    Trastuzumab

    4.2. Global Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Hospitals

    Clinics

    Others

    4.3. Global Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Oral

    Parenteral

    5. Gastric Cancer Drugs Market Regional And Country Analysis

    5.1. Global Gastric Cancer Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    5.2. Global Gastric Cancer Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6. Asia-Pacific Gastric Cancer Drugs Market  

    6.1. Asia-Pacific Gastric Cancer Drugs Market Overview  

    6.2. Asia-Pacific Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6.3. Asia-Pacific Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    7. China Gastric Cancer Drugs Market  

    7.1. China Gastric Cancer Drugs Market Overview  

    7.2. China Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    7.3. China Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    8. India Gastric Cancer Drugs Market  

    8.1. India Gastric Cancer Drugs Market Overview  

    8.2. India Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    8.3. India Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9. Japan Gastric Cancer Drugs Market  

    9.1. Japan Gastric Cancer Drugs Market Overview  

    9.2. Japan Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9.3. Japan Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10. Australia Gastric Cancer Drugs Market  

    10.1. Australia Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10.2. Australia Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11. Indonesia Gastric Cancer Drugs Market  

    11.1. Indonesia Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11.2. Indonesia Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12. South Korea Gastric Cancer Drugs Market  

    12.1. South Korea Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12.2. South Korea Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13. Western Europe Gastric Cancer Drugs Market  

    13.1. Western Europe Gastric Cancer Drugs Market Overview

    13.2. Western Europe Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13.3. Western Europe Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14. UK Gastric Cancer Drugs Market  

    14.1. UK Gastric Cancer Drugs Market Overview

    14.2. UK Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14.3. UK Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15. Germany Gastric Cancer Drugs Market  

    15.1. Germany Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15.2. Germany Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16. France Gastric Cancer Drugs Market  

    16.4. France Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16.5. France Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17. Eastern Europe Gastric Cancer Drugs Market  

    17.1. Eastern Europe Gastric Cancer Drugs Market Overview

    17.2. Eastern Europe Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17.3. Eastern Europe Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18. Russia Gastric Cancer Drugs Market  

    18.1. Russia Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18.2. Russia Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19. North America Gastric Cancer Drugs Market  

    19.1. North America Gastric Cancer Drugs Market Overview

    19.2. North America Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19.3. North America Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20. USA Gastric Cancer Drugs Market  

    20.1. USA Gastric Cancer Drugs Market Overview

    20.2. USA Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20.3. USA Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21. South America Gastric Cancer Drugs Market  

    21.1. South America Gastric Cancer Drugs Market Overview

    21.2. South America Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21.3. South America Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22. Brazil Gastric Cancer Drugs Market  

    22.1. Brazil Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22.2. Brazil Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23. Middle East Gastric Cancer Drugs Market  

    23.1. Middle East Gastric Cancer Drugs Market Overview

    23.2. Middle East Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23.3. Middle East Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24. Africa Gastric Cancer Drugs Market  

    24.1. Africa Gastric Cancer Drugs Market Overview

    24.2. Africa Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24.3. Africa Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    25. Gastric Cancer Drugs Market Competitive Landscape And Company Profiles

    25.1. Gastric Cancer Drugs Market Competitive Landscape

    25.2. Gastric Cancer Drugs Market Company Profiles

    25.2.1. Eli Lilly and company

    25.2.1.1. Overview

    25.2.1.2. Products and Services

    25.2.1.3. Strategy

    25.2.1.4. Financial Performance

    25.2.2. Novartis

    25.2.2.1. Overview

    25.2.2.2. Products and Services

    25.2.2.3. Strategy

    25.2.2.4. Financial Performance

    25.2.3.  Merck KGaA

    25.2.3.1. Overview

    25.2.3.2. Products and Services

    25.2.3.3. Strategy

    25.2.3.4. Financial Performance

    25.2.4. Otsuka Pharmaceutical

    25.2.4.1. Overview

    25.2.4.2. Products and Services

    25.2.4.3. Strategy

    25.2.4.4. Financial Performance

    25.2.5. F. Hoffmann-La Roche

    25.2.5.1. Overview

    25.2.5.2. Products and Services

    25.2.5.3. Strategy

    25.2.5.4. Financial Performance

    26. Key Mergers And Acquisitions In The Gastric Cancer Drugs Market

    27. Gastric Cancer Drugs Market Trends And Strategies

    28. Product Pipeline Analysis

    29. Gastric Cancer Drugs Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2014-2018, $ Billion
  • Table 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
  • Table 3: Global Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 4: Global Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 5: Global Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 6: Global Gastric Cancer Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 7: Global Gastric Cancer Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 8: Asia-Pacific, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 9: Asia-Pacific, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 10: China, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 11: China, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 12: India, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 13: India, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 14: Japan, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 15: Japan, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 16: Australia, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 17: Australia, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 18: Indonesia, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 19: Indonesia, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 20: South Korea, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 21: South Korea, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 22: Western Europe, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 23: Western Europe, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 24: UK, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 25: UK, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 26: Germany, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 27: Germany, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 28: France, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 29: France, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 30: Eastern Europe, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 31: Eastern Europe, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 32: Russia, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 33: Russia, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 34: North America, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 35: North America, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 36: USA, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 37: USA, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 38: South America, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 39: South America, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 40: Brazil, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 41: Brazil, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 42: Middle East, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 43: Middle East, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 44: Africa, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 45: Africa, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 46: Eli Lilly and company Financial Performance
  • Table 47: Novartis Financial Performance
  • Table 48:  Merck KGaA Financial Performance
  • Table 49: Otsuka Pharmaceutical Financial Performance
  • Table 50: F. Hoffmann-La Roche Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2014-2018, $ Billion
  • Figure 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
  • Figure 3: Global Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 4: Global Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 5: Global Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 6: Global Gastric Cancer Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 7: Global Gastric Cancer Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 8: Asia-Pacific, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 9: Asia-Pacific, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 10: China, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 11: China, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 12: India, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 13: India, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 14: Japan, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 15: Japan, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 16: Australia, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 17: Australia, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 18: Indonesia, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 19: Indonesia, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 20: South Korea, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 21: South Korea, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 22: Western Europe, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 23: Western Europe, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 24: UK, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 25: UK, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 26: Germany, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 27: Germany, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 28: France, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 29: France, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 30: Eastern Europe, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 31: Eastern Europe, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 32: Russia, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 33: Russia, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 34: North America, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 35: North America, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 36: USA, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 37: USA, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 38: South America, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 39: South America, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 40: Brazil, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 41: Brazil, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 42: Middle East, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 43: Middle East, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 44: Africa, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 45: Africa, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 46: Eli Lilly and company Financial Performance
  • Figure 47: Novartis Financial Performance
  • Figure 48:  Merck KGaA Financial Performance
  • Figure 49: Otsuka Pharmaceutical Financial Performance
  • Figure 50: F. Hoffmann-La Roche Financial Performance
Research And Development Initiatives Taken In The Anti-Infective Drugs Market
Research Initiatives And Funding And Demand For New Medicines For Drug-Resistant Infections In The Anti-Infective Drugs Industry
Global Biologics Market, Opportunities And Strategies Market | Characteristics, Forecast Size, Trends
Biologics Market By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), By Trends, By Regions and By Key Players - Global Forecast To 2021
View Report
Pharmaceutical Drugs Market By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs) - Global Forecast To 2022
View Report
Cardiovascular Drugs Global Market Report 2019
View Report
Dermatology Drugs Global Market Report 2019
View Report
Gastrointestinal Drugs Global Market Report 2019
View Report
Hematology Drugs Global Market Report 2019
View Report
Metabolic Disorders Drugs Global Market Report 2019
View Report
Musculoskeletal Disorders Drugs Global Market Report 2019
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)